120 related articles for article (PubMed ID: 26987716)
21. The involvement of p62-Keap1-Nrf2 antioxidative signaling pathway and JNK in the protection of natural flavonoid quercetin against hepatotoxicity.
Ji LL; Sheng YC; Zheng ZY; Shi L; Wang ZT
Free Radic Biol Med; 2015 Aug; 85():12-23. PubMed ID: 25881548
[TBL] [Abstract][Full Text] [Related]
22. Tetrachlorobenzoquinone activates Nrf2 signaling by Keap1 cross-linking and ubiquitin translocation but not Keap1-Cullin3 complex dissociation.
Su C; Zhang P; Song X; Shi Q; Fu J; Xia X; Bai H; Hu L; Xu D; Song E; Song Y
Chem Res Toxicol; 2015 Apr; 28(4):765-74. PubMed ID: 25742418
[TBL] [Abstract][Full Text] [Related]
23. Alterations in the Nrf2-Keap1 signaling pathway and its downstream target genes in rat brain under stress.
Djordjevic J; Djordjevic A; Adzic M; Mitic M; Lukic I; Radojcic MB
Brain Res; 2015 Mar; 1602():20-31. PubMed ID: 25598205
[TBL] [Abstract][Full Text] [Related]
24. The emerging role of the Nrf2-Keap1 signaling pathway in cancer.
Jaramillo MC; Zhang DD
Genes Dev; 2013 Oct; 27(20):2179-91. PubMed ID: 24142871
[TBL] [Abstract][Full Text] [Related]
25. Toward clinical application of the Keap1-Nrf2 pathway.
Suzuki T; Motohashi H; Yamamoto M
Trends Pharmacol Sci; 2013 Jun; 34(6):340-6. PubMed ID: 23664668
[TBL] [Abstract][Full Text] [Related]
26. Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2.
Sun Z; Zhang S; Chan JY; Zhang DD
Mol Cell Biol; 2007 Sep; 27(18):6334-49. PubMed ID: 17636022
[TBL] [Abstract][Full Text] [Related]
27. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth.
Ohta T; Iijima K; Miyamoto M; Nakahara I; Tanaka H; Ohtsuji M; Suzuki T; Kobayashi A; Yokota J; Sakiyama T; Shibata T; Yamamoto M; Hirohashi S
Cancer Res; 2008 Mar; 68(5):1303-9. PubMed ID: 18316592
[TBL] [Abstract][Full Text] [Related]
28. Human age‑related cataracts: epigenetic suppression of the nuclear factor erythroid 2‑related factor 2‑mediated antioxidant system.
Gao Y; Yan Y; Huang T
Mol Med Rep; 2015 Feb; 11(2):1442-7. PubMed ID: 25370996
[TBL] [Abstract][Full Text] [Related]
29. Activation of the Kelch-like ECH-associated protein 1 (Keap1)/NF-E2-related factor 2 (Nrf2) pathway through covalent modification of the 2-alkenal group of aliphatic electrophiles in Coriandrum sativum L.
Abiko Y; Mizokawa M; Kumagai Y
J Agric Food Chem; 2014 Nov; 62(45):10936-44. PubMed ID: 25307732
[TBL] [Abstract][Full Text] [Related]
30. Keap1/Nrf2 pathway in the frontiers of cancer and non-cancer cell metabolism.
Chartoumpekis DV; Wakabayashi N; Kensler TW
Biochem Soc Trans; 2015 Aug; 43(4):639-44. PubMed ID: 26551705
[TBL] [Abstract][Full Text] [Related]
31. The role of Nrf2 in pathology of pleomorphic adenoma in parotid gland.
Droździk A; Kowalczyk R; Jaworowska E; Urasińska E; Kurzawski M
Med Sci Monit; 2015 Apr; 21():1243-8. PubMed ID: 25928388
[TBL] [Abstract][Full Text] [Related]
32. Expression and clinical significance of Kelch-like epichlorohydrin-associated protein 1 in breast cancer.
Zhang L; Yang WP; Wu LY; Zhu X; Wei CY
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323010
[TBL] [Abstract][Full Text] [Related]
33. Acetyl-l-carnitine prevents homocysteine-induced suppression of Nrf2/Keap1 mediated antioxidation in human lens epithelial cells.
Yang SP; Yang XZ; Cao GP
Mol Med Rep; 2015 Jul; 12(1):1145-50. PubMed ID: 25776802
[TBL] [Abstract][Full Text] [Related]
34. Dysregulation of the Keap1-Nrf2 pathway in cancer.
Leinonen HM; Kansanen E; Pölönen P; Heinäniemi M; Levonen AL
Biochem Soc Trans; 2015 Aug; 43(4):645-9. PubMed ID: 26551706
[TBL] [Abstract][Full Text] [Related]
35. Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway.
Yu M; Li H; Liu Q; Liu F; Tang L; Li C; Yuan Y; Zhan Y; Xu W; Li W; Chen H; Ge C; Wang J; Yang X
Cell Signal; 2011 May; 23(5):883-92. PubMed ID: 21262351
[TBL] [Abstract][Full Text] [Related]
36. The Keap1-Nrf2 system as an in vivo sensor for electrophiles.
Uruno A; Motohashi H
Nitric Oxide; 2011 Aug; 25(2):153-60. PubMed ID: 21385624
[TBL] [Abstract][Full Text] [Related]
37. Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features.
Solis LM; Behrens C; Dong W; Suraokar M; Ozburn NC; Moran CA; Corvalan AH; Biswal S; Swisher SG; Bekele BN; Minna JD; Stewart DJ; Wistuba II
Clin Cancer Res; 2010 Jul; 16(14):3743-53. PubMed ID: 20534738
[TBL] [Abstract][Full Text] [Related]
38. Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin.
Tanigawa S; Fujii M; Hou DX
Free Radic Biol Med; 2007 Jun; 42(11):1690-703. PubMed ID: 17462537
[TBL] [Abstract][Full Text] [Related]
39. Activation of the Nrf2/ARE pathway via S-alkylation of cysteine 151 in the chemopreventive agent-sensor Keap1 protein by falcarindiol, a conjugated diacetylene compound.
Ohnuma T; Nakayama S; Anan E; Nishiyama T; Ogura K; Hiratsuka A
Toxicol Appl Pharmacol; 2010 Apr; 244(1):27-36. PubMed ID: 20026152
[TBL] [Abstract][Full Text] [Related]
40. Discovery of the negative regulator of Nrf2, Keap1: a historical overview.
Itoh K; Mimura J; Yamamoto M
Antioxid Redox Signal; 2010 Dec; 13(11):1665-78. PubMed ID: 20446768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
